SCA Pharmaceuticals Recalls Magnesium Sulfate Injection Bags Due to Sterility Concerns
SCA Pharmaceuticals is recalling 40 bags of Magnesium Sulfate 4 g in 0.9% Sodium Chloride because they were made with recalled saline bags that may leak, compromising sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of sterility failure in an injectable medication.
Plain-English summary
SCA Pharmaceuticals is recalling 40 bags of Magnesium Sulfate 4 g added to 100 mL 0.9% Sodium Chloride, Single Dose Container bag (NDC: 70004-0737-32). The recall is due to a lack of assurance of sterility, as the product was manufactured using recalled 0.9% sodium chloride bags that have the potential to leak.
The affected product is prescription-only and was distributed nationwide in the USA. The specific lot number is 20170710@54, with a beyond-use date of 10/8/2017.
Healthcare providers and patients should stop using the affected product and contact SCA Pharmaceuticals at (877) 550-5059 for further instructions or to arrange for a return or replacement.
The recalled product
- Product
- MAGNESIUM Sulfate 4 g added to 100 mL 0.9% Sodium Chloride, Total Approximate Volume 108 mL (does not include mfg. overfill) Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205 (877) 550-5059; NDC: 70004-0737-32.
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injectable Solution
- Hazard
- Affected units
- 40
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 20170710@54
- BUD: 10/8/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereSCA Pharmaceuticals Recalls Leaking Magnesium Sulfate Injectable Bags
FDA (Drugs) · 2017-06-07
- SevereSCA Pharmaceuticals Recalls Morphine Sulfate Injectable Bags Due to Leaking
FDA (Drugs) · 2017-06-07
- SevereSCA Pharmaceuticals Recalls Potassium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-02
- SevereSCA Pharmaceuticals Recalls Calcium Gluconate Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-08
- SevereSCA Pharmaceuticals Recalls Cefazolin Sodium Bags Due to Leaking
FDA (Drugs) · 2017-06-07
- SevereSCA Pharmaceuticals Recalls Fentanyl Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-06-07